Wen Li

机构：University of California, San Francisco, University of California System · ORCID：0000-0001-6584-363X

发表论文 89 篇 · 总被引 1003 次 · h-index 17

代表论文

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial (2024 · Nature Medicine · 被引 47)
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors (2025 · Nature Communications · 被引 16)
Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial (2024 · Nature Medicine · 被引 13)
Automatic phantom-less calibration of routine CT scans for the evaluation of osteoporosis and hip fracture risk (2025 · Bone · 被引 7)
High-Yield Production of Solution-Processed Highly Robust Organic Artificial Synapses by Thermal Treatments (2024 · ACS Applied Materials & Interfaces · 被引 6)
MRI-Based Model for Personalizing Neoadjuvant Treatment in Breast Cancer (2025 · Tomography · 被引 5)